Showing posts with label PA Board Of Pharmacy Newsletter Addresses Compounding of Hydroxyprogesterone Caproate Versus Dispensing the Commercial Product. Show all posts
Showing posts with label PA Board Of Pharmacy Newsletter Addresses Compounding of Hydroxyprogesterone Caproate Versus Dispensing the Commercial Product. Show all posts

Sunday, March 24, 2013

PA Board Of Pharmacy Newsletter Addresses Compounding of Hydroxyprogesterone Caproate Versus Dispensing the Commercial Product, Makena®


This article is written by  Gayle Cotchen, PharmD, Lead Pharmacist, Magee-Womens Hospital of the University of Pittsburgh Medical Center (UPMC),  a graduate of Duquesne University’s School of Pharmacy, and the current acute care institutional member of the State Board of Pharmacy.  To read the newsletter, click here